Search Ontology:
ChEBI

pazopanib

Term ID
CHEBI:71219
Synonyms
  • 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide
  • GW 78603
  • GW786034
  • pazopanib
  • pazopanibum
Definition
A pyrimidine that is 5-(pyrimidin-2-yl}amino-2-methylbenzenesulfonamide substituted at position 4 by a (2,3-dimethylindazol-6-yl)(methyl)amino group. Used as its hydrochloride salt for treatment of kidney cancer.
References
  • cas:444731-52-6
  • drugcentral:4118
  • lincs.smallmolecule:LSM-1114
  • patent:US2008293691
  • patent:WO2006020564
  • patent:WO2007064753
  • patent:WO2007143483
  • patent:WO2011058179
  • patent:WO2011069053
  • patent:WO2011150044
  • patent:WO2012106302
  • pubmed:21394443
  • pubmed:21766486
  • pubmed:21811833
  • pubmed:22112314
  • pubmed:22190407
  • pubmed:22233389
  • pubmed:22341567
  • pubmed:22359392
  • pubmed:22595799
  • pubmed:22679111
  • pubmed:22688250
  • pubmed:22716487
  • pubmed:22733110
  • pubmed:22733795
  • pubmed:22759480
  • pubmed:22766517
  • pubmed:22830347
  • pubmed:22861374
  • pubmed:22917595
  • pubmed:22984765
  • pubmed:23054212
  • pubmed:23064954
  • pubmed:23072642
  • pubmed:23088634
  • pubmed:23135778
  • reaxys:11646488
  • wikipedia.en:Pazopanib
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from pazopanib
Phenotype where environments contain pazopanib
Phenotype modified by environments containing pazopanib
Phenotype affecting pazopanib
Human Disease Model